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Platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is a potent lipid mediator with 
diverse activities.  Our previous studies have demonstrated that oxidized glycerophosphocholines 
(OxGPCs) that act as agonists for the Platelet-activating factor receptor (PAF-R) mediate ultraviolet B 
radiation (UVB) induced systemic immunosuppression in a process involving IL-10.  However, the exact 
role of UVB-mediated systemic immunosuppression in pathophysiological processes remains unclear.  
The current studies sought to define whether UVB-induced systemic immunosuppression could 
modulate experimental murine melanoma tumor growth.  Using a murine UVB model of systemic 
immunosuppression, we demonstrate that UVB exposure to a remote site from skin implanted with 
subcutaneous B16F10 melanoma results in enhanced tumor growth in C57BL/6 (wild-type) mice but not 
in PAF-R-deficient mice.  We further show that intraperitoneal injection of the PAF agonist carbamoyl-
PAF (CPAF) mimicked the UVB effect.  Interestingly, neutralizing antibody against IL-10 blocked both 
CPAF- and UVB-mediated augmentation of B16F10 tumor growth.  The next studies were designed to 
define whether the PAF-R effect was due to direct effects on B16F10 cells.  Of note, B16F10 cells lack 
functional PAF-R expression.  To address this question, we first generated PAF-R expressing B16F10 
(B16-PAFR) and its vector control B16-MSCV cells by retroviral transduction and confirmed the presence 
of PAF-R in B16-PAF-R cells by intracellular Ca2+ flux in response to CPAF and qRT-PCR.  Transplantation 
of B16-PAFR cells into mice did not result in an increased rate of tumor growth over control B16-MSCV 
cells either alone, or in response to UVB or CPAF.  These studies provide a novel unreported effect of 
UVB-mediated PAF agonists, namely, that they can augment melanoma tumor growth via IL-10. 
